Identification and characterization of the novel human prostate cancer-specific PC-1 gene promoter

Biochemical and Biophysical Research Communications

Volumn 357, Issue 1, 2007, Pages 8-13

  Wang, Jian ^a   Zhang, Hui ^a   Liang, Rui Xia ^a   Pang, Bo ^a   Shi, Qing Guo ^a   Huang, Pei Tang ^a   Huang, Cui Fen ^a   Zhou, Jian Guang ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

Gene therapy; PC 1 gene; Promoter; Prostate cancer

Indexed keywords

LUCIFERASE;

5' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE REPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOME; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE AND COLON GENE 1; PROSTATE CANCER; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHOSPHORIC DIESTER HYDROLASES; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PYROPHOSPHATASES; REGULATORY SEQUENCES, NUCLEIC ACID; TRANS-ACTIVATION (GENETICS);

EID: 34247117649     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.153     Document Type: Article

References (23)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., Feuer E.J., and Thun M.J. Cancer statistics, 2005. CA Cancer J. Clin. 55 (2005) 10-30
2. Horoszewicz J.S., Leong S.S., Chu T.M., Wajsman Z.L., Friedman M., Papsidero L., Kim U., Chai L.S., Kakati S., Arya S.K., and Sandberg A.A. The LNCaP cell line-a new model for studies on human prostatic carcinoma. Prog. Clin. Biol. Res. 37 (1980) 115-132
3. Thalmann G.N., Anezinis P.E., Chang S.M., Zhau H.E., Kim E.E., Hopwood V.L., S P., von Eschenbach A.C., and Chung L.W. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res. 54 (1994) 2577-2581
4. Thalmann G.N., Sikes R.A., Wu T.T., Degeorges A., Chang S.M., Ozen M., Pathak S., and Chung L.W. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44 (2000) 91-103
5. Wang R., Xu J., Saramaki O., Visakorpi T., Sutherland W.M., Zhou J., Sen B., Lim S.D., Mabjeesh N., Amin M., Dong J.T., Petros J.A., Nelson P.S., Marshall F.F., Zhau H.E., and Chung L.W. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res. 64 (2004) 1589-1594
6. Byrne J.A., Tomasetto C., Garnier J.M., Rouyer N., Mattei M.G., Bellocq J.P., Rio M.C., and Basset P. A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence. Cancer Res. 55 (1995) 2896-2903
7. Chen S.L., Maroulakou I.G., Green J.E., Romano-Spica V., Modi W., Lautenberger J., and Bhat N.K. Isolation and characterization of a novel gene expressed in multiple cancers. Oncogene 12 (1996) 741-751
8. Byrne J.A., Balleine R.L., Fejzo M.S., Mercieca J., Chiew Y.E., Livnat Y., St Heaps L., Peters G.B., Byth K., Karlan B.Y., Slamon D.J., Harnett P., and Defazio A. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. Int. J. Cancer. 117 (2005) 1049-1054
9. Chang X.T., Liang R.X., Zhou J.G., Zhang H., Li J.Z., Wang J., Zhang H., and Huang C.F. Malignant transformation of NIH3T3 cells induced by ectopic expression of PC-1 gene. Zhonghua Bing Li Xue Za Zhi. 34 (2005) 42-46 (Article in Chinese)
10. Zhang H., Wan L.C., Wang J., Zhou J.G., and Huang C.F. Effect of PC-1 gene expression on migration ability of prostate cancer cells. Ai Zheng 24 (2005) 1043-1047 (Article in Chinese)
11. Zhou L.Q., Zhang H., Gao X.S., Wang J., Liang R.X., Hong B.F., and Zhou J.G. Impact of PC-1 gene knockdown on the biological action of prostate cancer cell line C4-2. Zhonghua Nan Ke Xue. 11 (2005) 256-260 (Article in Chinese)
12. Visakorpi T., Kallioniemi A.H., Syvanen A.C., Hyytinen E.R., Karhu R., Tammela T., Isola J.J., and Kallioniemi O.P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res. 55 (1995) 342-347
13. Marks-Konczalik J., Chu S.C., and Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J. Biol. Chem. 273 (1998) 22201-22208
14. Riegman P.H., Vlietstra R.J., van der Korput J.A., Brinkmann A.O., and Trapman J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol. 5 (1991) 1921-1930
15. Cleutjens K.B., van der Korput H.A., van Eekelen C.C., van Rooij H.C., Faber P.W., and Trapman J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 11 (1997) 148-161
16. Latham J.P., Searle P.F., Mautner V., and James N.D. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Cancer Res. 60 (2000) 334-341
17. Shi C.X., Hitt M., Ng P., and Graham F.L. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors. Hum. Gene. Ther. 13 (2002) 211-224
18. Gotoh A., Ko S.C., Shirakawa T., Cheon J., Kao C., Miyamoto T., Gardner T.A., Ho L.J., Cleutjens C.B., Trapman J., Graham F.L., and Chung L.W. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. J. Urol. 160 (1998) 220-229
19. Brinkmann A.O., Blok L.J., de Ruiter P.E., Doesburg P., Steketee K., Berrevoets C.A., and Trapman J. Mechanisms of androgen receptor activation and function. J. Steroid. Biochem. Mol. Biol. 69 (1999) 307-313
20. Grad J.M., Dai J.L., Wu S., and Burnstein K.L. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA. Mol. Endocrinol. 13 (1999) 1896-1911
21. Gao S., Lee P., Wang H., Gerald W., Adler M., Zhang L., Wang Y.F., and Wang Z. The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. Mol. Endocrinol. 19 (2005) 1792-1802
22. Huang W., Shostak Y., Tarr P., Sawyers C., and Carey M. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J. Biol. Chem. 274 (1999) 25756-25768
23. Uchida A., O'Keefe D.S., Bacich D.J., Molloy P.L., and Heston W.D. In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy. Urology 58 (2001) 132-139